SELECTIVE ANTAGONISTS OF BETA3-ADRENERGIC RECEPTOR

The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and metho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	EVRARD DEBORAH ANN, CROWELL THOMAS ALAN, BELL MICHAEL GREGORY, RITO CHRISTOPHER JOHN, MC DONALD JOHN HAMPTON III, MATTHEWS DONALD PAUL, SHUKER ANTHONY JOHN, WINTER MARK ALAN
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective beta 3 receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a patient in need thereof compounds of the Formula I: